- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06831019
The ROAR Study: Reactive Oxygen Species and Reproduction (ROAR)
February 12, 2026 updated by: University of California, San Francisco
This is a prospective cohort study characterizing follicular fluid and serum levels of oxidative stress in women with various infertility diagnoses undergoing in vitro fertilization, and assessing the relationship of oxidative stress to oocyte competence as determined by embryo development outcomes.
Furthermore, we will measure oxidative stress in sperm and correlate the overall oxidative stress within the couple with IVF and pregnancy outcomes of the resultant embryos.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
1100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Elena Hoskin, BS
- Phone Number: (415) 885-3598
- Email: elena.hoskin@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94158
- Recruiting
- University of California, San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Heterosexual couples undergoing fresh IVF cycle
Description
Inclusion Criteria:
- Female age 18-43 years
- Subjects planning blastocyst culture for preimplantation genetic screening (PGS) for aneuploidy.
- Male partners 18 years of age or older.
- Must be a registered patient at UCSF Center for Reproductive Health
- Patient and partner must both be physically present on the day of retreival
Exclusion Criteria:
- Female partner age 44 or older
- Planning fresh transfer (hybrid PGS cycle)
- Cleavage stage biopsy
- Planning to use frozen sperm
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Couples undergoing IVF
Heterosexual couples undergoing IVF
|
We will measure markers of oxidative stress in the follicular fluid, semen, and blood and correlate this with IVF and reproductive outcomes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implantation rate
Time Frame: From enrollment to transfer of all embryos - can be anywhere from 8 weeks to 1 year (or sometimes longer if pregnancy is achieved)
|
Implantation rate of euploid embryos that result from a specific oxidative stress environment
|
From enrollment to transfer of all embryos - can be anywhere from 8 weeks to 1 year (or sometimes longer if pregnancy is achieved)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mitchell Rosen, MD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2025
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Study Registration Dates
First Submitted
February 13, 2025
First Submitted That Met QC Criteria
February 13, 2025
First Posted (Actual)
February 17, 2025
Study Record Updates
Last Update Posted (Actual)
February 17, 2026
Last Update Submitted That Met QC Criteria
February 12, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 24-42357
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oxidative Stress
-
University of ThessalyNot yet recruitingOxidative Stress
-
Universidad Europea de MadridCompleted
-
University of Ljubljana, Faculty of MedicineUniversity of LjubljanaCompleted
-
Carmel Medical CenterUnknown
-
Recep Tayyip Erdogan University Training and Research...Unknown
-
Tufts UniversityCompletedOxidative StressUnited States
-
Rigshospitalet, DenmarkKlinisk Biokemisk Afdeling; Klinisk farmakologisk Afdeling; Sektion for Biomedicin...Completed
-
Universidad Miguel Hernandez de ElcheVitalgrana Pomegranate SLCompleted
-
Charles Drew University of Medicine and ScienceCompletedOxidative StressUnited States
-
University of British ColumbiaAquaceutica GroupTerminated
Clinical Trials on Oxidative stress markers
-
Merve Erkmen AlmazKırıkkale UniversityCompletedDental Caries | Oxidative Stress | Passive Smoking
-
University of ChileHospital del SalvadorCompletedHeart Failure | Atrial FibrillationChile
-
Carmel Medical CenterUnknown
-
Shahid Beheshti University of Medical SciencesCompletedOxidative StressIran, Islamic Republic of
-
Uniwersytet Mikolaja Kopernika w ToruniuUnknownKidney TransplantationPoland
-
Swansea Bay University Health BoardRecruitingCoronary Artery Disease | Diabetes Mellitus | Acute Coronary SyndromeUnited Kingdom
-
University Hospital, Clermont-FerrandUniversity Hospital, Limoges; Institut National de Recherche pour l'Agriculture...Unknown
-
Grigore T. Popa University of Medicine and PharmacyCardiovascular Diseases Institute IASI, RomaniaUnknownOxidative Stress | STEMI | Left Ventricular Dysfunction | Oxidative Stress Induction | Primary PCI | hFABP | BCMRomania
-
Clinique OvoFerring PharmaceuticalsCompletedFertility PreservationCanada
-
Catholic University of the Sacred HeartRecruitingCANVAS SyndromeItaly